welcome to oneGRAVESvoice- a positively charged Graves' disease and thyroid eye disease community.
- join today!
- log in
Steven Elliott Feldon, MD, MBA
Strong Flaum Eye Institute
210 Crittenden Blvd, Floor 3
Rochester, New York, United States
Steven Elliott Feldon is an internationally acclaimed clinical and basic scientist with a specialty in orbital disease and neuro-ophthalmology. In 2001, he was appointed Chair of the University of Rochester Department of Ophthalmology, and is now Director of the Flaum Eye Institute.
Dr. Feldon earned his medical degree from the Albert Einstein College of Medicine. He completed his residency at the Massachusetts Eye & Ear Infirmary, Harvard University, along with a research fellowship in neurosurgery at Massachusetts General Hospital, and a clinical fellowship in neuro-ophthalmology at the University of California Medical Center, San Francisco.
Devoted to patient care, Dr. Feldon’s special interest is in the management of patients with thyroid-associated eye disease. Cranial nerve palsies, disorders of the optic nerve, visual field loss, and eye movement problems are all his specialty areas. Now leading a world-class team of eye care specialists, his clinical expertise has been recognized in “Best Doctors in America.”
An inventor of ophthalmic instruments and a scientific investigator, Dr. Feldon is involved in a number of local and national clinical trials and basic science collaborations. He is the former President of the North American Neuro-Ophthalmic Society and the current Executive Vice President of the Association of University Professors of Ophthalmology.
Management of Patients With Graves’ Orbitopathy: Initial Assessment, Management Outside Specialised Centres and Re...Graves' orbitopathy (GO) is uncommon, bu...
Advances in Treatment of Active, Moderate-To-Severe Graves’ OphthalmopathyGraves' ophthalmopathy is defined as aut...
Dr. Alon Kahana – Management of Dry Eyeshttps://www.youtube.com/watch?v=xat5SBU_...
Recent Developments in Graves’ OphthalmopathyRecent Developments in Graves' ophthalmo...
High Serum Cholesterol is a Novel Risk Factor for Graves’ Orbitopathy: Results of a Cross-Sectional StudyBackground: Limited data suggest that t...
Andrea Lora Kossler, MD, FACSAndrea Lora Kossler, MD, is Assistant Pr...
Comparison of Two Different Regimens of Intravenous Methylprednisolone for Patients With Moderate to Severe and Acti...The intravenous methylprednisolone (iv M...